Insider Selling: Astera Labs (NASDAQ:ALAB) CEO Sells 123,750 Shares of Stock

Key Points

• Astera Labs CEO Jitendra Mohan sold 123,750 shares on April 10 at an average price of $149.68 for about $18.5 million, executed under a pre‑arranged Rule 10b5‑1 plan and reducing his stake by 2.73% to 4,407,982 shares.
• The April sale continues a recent pattern of insider selling — Mohan sold 157,500 shares on March 17 (≈$20.7M) and 94,971 shares on February 17 (≈$11.8M).
• For context, ALAB shares traded at $170.60 with a $29.2B market cap; the company reported a Q4 beat (EPS $0.58 vs. $0.51, revenue $270.6M, +91.8% YoY), set Q1 2026 guidance of $0.530–0.540, and carries a consensus analyst rating of "Moderate Buy" with a $199.44 target.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) CEO Jitendra Mohan sold 123,750 shares of Astera Labs stock in a transaction on Friday, April 10th. The shares were sold at an average price of $149.68, for a total value of $18,522,900.00. Following the completion of the transaction, the chief executive officer directly owned 4,407,982 shares of the company's stock, valued at $659,786,745.76. This represents a 2.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jitendra Mohan also recently made the following trade(s):

• On Tuesday, March 17th, Jitendra Mohan sold 157,500 shares of Astera Labs stock. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00.
• On Tuesday, February 17th, Jitendra Mohan sold 94,971 shares of Astera Labs stock. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51.

Astera Labs Stock Performance

Shares of Astera Labs stock traded up $3.81 during trading on Tuesday, reaching $170.60. 7,634,199 shares of the company's stock were exchanged, compared to its average volume of 4,681,923. Astera Labs, Inc. has a 1-year low of $52.56 and a 1-year high of $262.90. The company has a market cap of $29.22 billion, a P/E ratio of 154.44, a PEG ratio of 3.28 and a beta of 1.78. The firm's 50-day moving average price is $128.40 and its 200 day moving average price is $154.49.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts' consensus estimates of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs's quarterly revenue was up 91.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Technical momentum: multiple reports highlight a jump in Astera Labs’ relative strength rating (to the high 80s) and rising relative price strength, signaling strong institutional/investor interest that’s boosting the stock. Read More.
• Positive Sentiment: Operational/growth optimism: coverage notes a high double-digit growth outlook and a seven-day winning streak tied to the company’s Q1 beat and optimistic guidance, which is supporting the rally. Read More.
• Positive Sentiment: Fundamental bull case: a long-form bullish piece reiterates a "Strong Buy" view, arguing ALAB is evolving from hardware into a broader platform (COSMOS/Scorpio X roadmap), expanding TAM and multi-product revenue drivers. Read More.
• Positive Sentiment: Institutional/insider interest theme: ALAB appears on lists of top growth stocks with strong insider ownership — a signal some investors use to justify higher conviction in growth names. Read More.
• Neutral Sentiment: Price-action scrutiny: market notes that recent gains occurred on above-average volume but also point out that recent earnings-estimate revisions don’t clearly support continued acceleration — suggesting momentum may need fresh fundamental catalysts to sustain. Read More.
• Neutral Sentiment: Macro headwinds: broader market sensitivity to rising inflation and oil prices could introduce near-term volatility that affects growth/high-beta names like ALAB despite company-specific strength. Read More.
• Negative Sentiment: Analyst target cut: Citi trimmed its price target from $250 to $200 (while keeping a Buy rating), citing AI-related considerations — this reduces some upside and could pressure sentiment if other firms follow. Read More.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on ALAB shares. Weiss Ratings lowered Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a report on Monday, February 23rd. Citigroup assumed coverage on Astera Labs in a report on Thursday, April 2nd. They set a "buy" rating and a $200.00 price objective for the company. Loop Capital assumed coverage on Astera Labs in a report on Thursday, March 5th. They set a "buy" rating and a $250.00 price objective for the company. Barclays set a $165.00 price objective on Astera Labs in a report on Thursday, January 15th. Finally, Royal Bank Of Canada assumed coverage on Astera Labs in a report on Wednesday, January 14th. They set an "outperform" rating and a $225.00 price objective for the company. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $199.44.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently made changes to their positions in ALAB. Vanguard Group Inc. grew its stake in shares of Astera Labs by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company's stock worth $2,300,344,000 after purchasing an additional 84,365 shares during the last quarter. State Street Corp grew its stake in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company's stock worth $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Astera Labs by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company's stock worth $403,598,000 after purchasing an additional 104,935 shares during the last quarter. Fred Alger Management LLC grew its stake in shares of Astera Labs by 25.5% in the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company's stock worth $321,855,000 after purchasing an additional 393,250 shares during the last quarter. Finally, Morgan Stanley grew its stake in shares of Astera Labs by 33.0% in the fourth quarter. Morgan Stanley now owns 1,934,467 shares of the company's stock worth $321,818,000 after purchasing an additional 480,009 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.